Ignite Creation Date:
2025-12-24 @ 4:33 PM
Ignite Modification Date:
2026-01-31 @ 1:26 AM
Study NCT ID:
NCT03625466
Status:
COMPLETED
Last Update Posted:
2022-11-02
First Post:
2018-08-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Explore the Impact of Lumacaftor/Ivacaftor on Disease Progression in Subjects Aged 2 Through 5 Years With Cystic Fibrosis, Homozygous for F508del
Sponsor:
Vertex Pharmaceuticals Incorporated
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-08-10
Start Date Type:
ACTUAL
Primary Completion Date:
2020-10-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-10-07
Completion Date Type:
ACTUAL
First Submit Date:
2018-08-07
First Submit QC Date:
None
Study First Post Date:
2018-08-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-10-08
Results First Submit QC Date:
None
Results First Post Date:
2021-12-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-06
Last Update Post Date:
2022-11-02
Last Update Post Date Type:
ACTUAL